Specialty Pharmacy Services

Oncology and Hematology Specialty Pharmacy

Accord Specialty Pharmacy provides oral oncology and hematology medication dispensing with close attention to adherence, financial barriers, and REMS compliance. We coordinate with oncology and hematology practices to support patients throughout their treatment.

Conditions We Serve

Oncology and Hematology Conditions

Chronic Myeloid Leukemia (CML)

A blood and bone marrow cancer in which the body produces too many abnormal white blood cells. Tyrosine kinase inhibitors (TKIs) such as imatinib, dasatinib, and nilotinib have dramatically changed the long-term outlook for CML patients and are dispensed through specialty pharmacies.

Gleevec Sprycel Tasigna

Gastrointestinal Stromal Tumors (GIST)

A type of tumor that begins in the gastrointestinal tract, most often driven by KIT or PDGFRA mutations. Imatinib (Gleevec) was the first TKI approved for GIST and remains a primary treatment option dispensed through specialty channels.

Immune Thrombocytopenia (ITP)

A disorder in which the immune system destroys platelets, leading to low platelet counts and increased bleeding risk. Thrombopoietin receptor agonists such as eltrombopag (Promacta) and romiplostim (Nplate) are specialty medications used when first-line treatments are insufficient.

Promacta Nplate

Prostate Cancer

Castration-resistant prostate cancer is treated with oral androgen pathway inhibitors including abiraterone (Zytiga) and enzalutamide (Xtandi). These oral oncology agents are dispensed through specialty pharmacies and require careful monitoring and adherence support.

Zytiga Xtandi

Hepatocellular and Renal Cell Carcinoma

Sorafenib (Nexavar) is a multi-kinase inhibitor approved for hepatocellular carcinoma and renal cell carcinoma. Like most oral TKIs, it is dispensed exclusively through specialty pharmacies and may require assistance navigating manufacturer support programs.

Specialty Support for Oncology and Hematology Patients

Oral Oncology Management

Oral cancer medications require diligent adherence monitoring. Accord provides refill coordination, adherence check-ins, and side effect counseling to help patients stay on therapy throughout their treatment course.

Prior Authorization Support

Our team assists with prior authorization for all dispensed oncology medications, including appeals when coverage is denied. We work urgently on oncology PAs given the time-sensitive nature of cancer treatment.

Financial Assistance Navigation

Many oral oncology medications have manufacturer copay programs that significantly reduce patient cost burden. We also identify foundation resources for patients who do not qualify for commercial copay programs.

Doorstep Delivery

Accord ships oral oncology medications to patients in states where Accord holds an active pharmacy license with discreet packaging and timely delivery coordinated around the patient's treatment schedule.

What We Dispense

Oncology and Hematology Specialty Medications

Dedicated Medication Pages

Additional Medications

Xtandi

enzalutamide

Prostate Cancer Oral

Imbruvica

ibrutinib

CLL, MCL Oral

Revlimid

lenalidomide

Multiple Myeloma Oral

Nplate

romiplostim

ITP Self-Injection

Tasigna

nilotinib

CML Oral

Not seeing a medication? Call us at 1-855-222-6730 to confirm availability.

Frequently Asked Questions

Does Accord carry oral TKIs for chronic myeloid leukemia?

Yes. Accord Specialty Pharmacy dispenses tyrosine kinase inhibitors for CML including imatinib (Gleevec), dasatinib (Sprycel), and nilotinib (Tasigna). Our team assists with prior authorization and coordinates refills on a schedule that aligns with the patient's oncology visits.

Can Accord dispense Promacta (eltrombopag) for immune thrombocytopenia?

Yes. Accord carries Promacta (eltrombopag) for immune thrombocytopenia and other approved hematological indications. We assist with prior authorization and enrollment in the manufacturer's patient support program.

How does Accord support oral oncology adherence?

Adherence to oral oncology regimens is critical for treatment success. Our team provides proactive refill coordination, regular adherence check-ins, and side effect counseling. We also alert the prescribing oncologist if a patient misses a refill or reports significant side effects.

Does Accord support prior authorization for oral cancer medications urgently?

Yes. We prioritize oncology prior authorizations given the time-sensitive nature of cancer treatment. Our team begins the PA process immediately upon receiving a complete referral and pursues same-day or next-day submissions whenever possible.

How do I refer an oncology patient to Accord?

Download the appropriate specialty referral form from our Referral Forms page. For oncology and hematology patients, include the diagnosis, ICD-10 code, prescription, and any relevant prior treatment history. Fax the completed form to 386-385-7871 and our team will confirm receipt within one business day.

What financial assistance programs are available for oral oncology medications?

Many oral oncology medications have manufacturer-sponsored copay assistance programs that can reduce costs substantially for commercially insured patients. For patients on Medicare or Medicaid, or those who do not qualify for copay programs, we identify independent foundation grants and patient assistance programs. Contact our team to discuss options for a specific medication.

For Patients

Ready to Transfer Your Prescription?

Call our team and we will coordinate the transfer, prior authorization, and financial assistance enrollment so you can stay focused on your treatment.

Call 1-855-222-6730

For Prescribers

Refer a Patient to Accord

Fax a completed referral form to 386-385-7871. We prioritize oncology referrals and confirm receipt within one business day.

Download Referral Form
Refer a Patient